Reducing antimicrobial resistance: accelerated efforts are needed to meet the EU targets
Data published by ECDC in connection with European Antibiotic Awareness Day shows that, despite improvement in some areas, the EU is lapsing in progress towards its 2030 antimicrobial resistance (AMR) targets.
Increased flu and COVID-19 vaccination recommended for risk groups in EU/EEA ahead of winter
Seasonal influenza and COVID-19 vaccination uptake for risk groups such as the elderly were sub-optimal in several EU/EEA Member States during the 2023-2024 season.
This executive summary sets out results derived from 2023 antimicrobial resistance (AMR) data, sourced from invasive isolates reported to both the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) network and the European Antimicrobial
Resistance Surveillance Network (EARS-Net).
In 2024, all European Union/European Economic Area (EU/EEA) countries reported data for 2023 to the European Antimicrobial Resistance Surveillance Network (EARS-Net).
For 2023, 27 countries (25 European Union (EU) Member States and two European Economic Area (EEA) countries – Iceland and Norway) reported data on antimicrobial consumption.
Join the ECDC Crowd and work on improving and transforming health science one task at a time with your insights on study design, statistical analysis, data collection and interpretation
About ECDC
ECDC collects, analyses and shares data on more than 50 infectious disease topics. ECDC experts assess risks to Europe and provide guidance to help countries prevent and respond to outbreaks and public health threats.
